InsidersTradesSigma
Follow the 20/20 Biolabs, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 23 February 2026 (C). Among the most active insiders: Rollins John Woodson. All data is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 February 2026
Declarations4 total
13,029 shares0Common StockSEC:0001213900-26-019456:0
31 shares0Common StockSEC:0001213900-26-019424:0
7,669 shares0Common StockSEC:0001213900-26-019423:0
7,700 shares0Common StockSEC:0001213900-26-019421:0
4 of 4 declarations
关于 20/20 Biolabs, Inc.
20/20 Biolabs, Inc. 是一家生物技术公司，专注于为研究和医疗应用开发创新解决方案。该公司在XNAS市场上市。